Guo Guangchang: FOSUN will leverage global industrial advantages to promote China's cutting-edge innovation

AASTOCKS
2025.11.06 02:21

FOSUN INTL (00656.HK) has participated in the China International Import Expo (CIIE) for the eighth consecutive year, showcasing innovative drugs, high-end medical devices, and international cooperation achievements at the FOSUN PHARMA (02196.HK) booth in the medical devices and healthcare exhibition area, with a focus on core treatment areas such as oncology, immune inflammation, central nervous system, and kidney diseases.

FOSUN Chairman Guo Guangchang stated that the CIIE has become a window for China to build a new development pattern, a platform for promoting high-level openness, and an international public good shared globally. Looking ahead, the innovation expectations in the pharmaceutical and healthcare fields should target unmet clinical needs. FOSUN will continue to leverage its global industrial advantages, integrate resources, and promote more cutting-edge innovative technologies to land in China

Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer